Back to Search
ROBERT DORR, MD
MD
Pediatrics Physician
NPI: 1831270297Individual
Specialties, Licenses & Credentials
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
023679(CT)
Research & Publications (20)
Phase I/II study of the P-glycoprotein modulator PSC 833 in patients with acute myeloid leukemia.
PMID 11250987·J Clin Oncol·2001
3-trial
A phase I trial of imexon, a pro-oxidant, in combination with docetaxel for the treatment of patients with advanced breast, non-small cell lung and prostate cancer.
PMID 19499186·Invest New Drugs·2010
3-trial
UA62784, a novel inhibitor of centromere protein E kinesin-like protein.
PMID 19139111·Mol Cancer Ther·2009
8-other
Synthesis, characterization, and anti-melanoma activity of tetra-O-substituted analogs of nordihydroguaiaretic acid.
PMID 19615898·Bioorg Med Chem Lett·2009
7-preclinical
Characterization of novel diaryl oxazole-based compounds as potential agents to treat pancreatic cancer.
PMID 19657049·J Pharmacol Exp Ther·2009
7-preclinical
Inhibition of protein synthesis by imexon reduces HIF-1alpha expression in normoxic and hypoxic pancreatic cancer cells.
PMID 18607542·Invest New Drugs·2009
8-other
Phase 1 study of topical perillyl alcohol cream for chemoprevention of skin cancer.
PMID 18444166·Nutr Cancer·2008
3-trial
Proteasomal inhibition stabilizes topoisomerase IIalpha protein and reverses resistance to the topoisomerase II poison ethonafide (AMP-53, 6-ethoxyazonafide).
PMID 18062937·Biochem Pharmacol·2008
8-other
Imexon-based combination chemotherapy in A375 human melanoma and RPMI 8226 human myeloma cell lines.
PMID 17333195·Cancer Chemother Pharmacol·2007
8-other
Ethonafide-induced cytotoxicity is mediated by topoisomerase II inhibition in prostate cancer cells.
PMID 17351106·J Pharmacol Exp Ther·2007
7-preclinical
The antitumor agent imexon activates antioxidant gene expression: evidence for an oxidative stress response.
PMID 17545547·Clin Cancer Res·2007
8-other
Therapeutic effect of anthracene-based anticancer agent ethonafide in an animal model of multiple sclerosis.
PMID 18025185·J Immunol·2007
7-preclinical
Simple and inexpensive hardware and software method to measure volume changes in Xenopus oocytes expressing aquaporins.
PMID 17178424·J Neurosci Methods·2007
7-preclinical
Simple multichannel system for the measurement of the net water flux across biological tissues.
PMID 17113182·Comput Methods Programs Biomed·2007
8-other
From membrane pores to aquaporins: 50 years measuring water fluxes.
PMID 19669522·J Biol Phys·2007
8-other
Cytotoxic activity of Apomine is due to a novel membrane-mediated cytolytic mechanism independent of apoptosis in the A375 human melanoma cell line.
PMID 17024575·Invest New Drugs·2007
8-other
Correlates of imexon sensitivity in human multiple myeloma cell lines.
PMID 16321833·Leuk Lymphoma·2006
8-other
Melanocortin peptide therapeutics: historical milestones, clinical studies and commercialization.
PMID 16412534·Peptides·2006
6-review
Preclinical antitumor activity, pharmacokinetics and pharmacodynamics of imexon in mice.
PMID 17075317·Anticancer Drugs·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 420 E MAIN ST # 6
BRANFORD, CT 06405 - Phone
- (203) 488-8345
Quick Facts
- NPI
- 1831270297
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile